|
PPP1R12A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.48099976726712E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03230000050958E-07 |
| Normal-vs-Stage2 |
1.09030000028376E-07 |
| Normal-vs-Stage3 |
2.50530041157049E-10 |
| Normal-vs-Stage4 |
5.46400036327555E-10 |
| Stage1-vs-Stage2 |
1.949220E-01 |
| Stage1-vs-Stage3 |
2.969700E-02 |
| Stage1-vs-Stage4 |
6.161900E-03 |
| Stage2-vs-Stage3 |
7.523600E-01 |
| Stage2-vs-Stage4 |
3.650600E-01 |
| Stage3-vs-Stage4 |
5.201600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01660002638226E-09 |
| Normal-vs-AfricanAmerican |
1.796790E-03 |
| Normal-vs-Asian |
2.71429999998407E-06 |
| Caucasian-vs-AfricanAmerican |
4.596400E-01 |
| Caucasian-vs-Asian |
9.900400E-01 |
| AfricanAmerican-vs-Asian |
5.009200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.42989978033381E-10 |
| Normal-vs-Female |
2.231000051367E-09 |
| Male-vs-Female |
5.612000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.1144000002874E-07 |
| Normal-vs-Age(41-60Yrs) |
6.41069997087129E-09 |
| Normal-vs-Age(61-80Yrs) |
8.53350723417634E-12 |
| Normal-vs-Age(81-100Yrs) |
4.200600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.331500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.461900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.209000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.096400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.937600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.073000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.292200E-02 |
| Classical-VS-Follicular |
4.800400E-01 |
| Classical-VS-Other |
4.937000E-01 |
| Classical-VS-Normal |
5.13730002982271E-09 |
| Tall-VS-Follicular |
1.138800E-01 |
| Tall-VS-Other |
5.907400E-01 |
| Tall-VS-Normal |
5.84519999069499E-09 |
| Follicular-VS-Other |
7.676800E-01 |
| Follicular-VS-Normal |
4.15769999995153E-06 |
| Other-VS-Normal |
7.898700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.47799994465458E-10 |
| Normal-vs-N1 |
1.10400000030708E-07 |
| N0-vs-N1 |
8.693600E-01 |
|
|
